Covered recipient · General Payments record
MANUEL S VERGARA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Epilepsy
General Payments · PY2018–2024
$2,049.88
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $442.77 | 35 |
| Education | $55.50 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $262.05 | 31 |
| Axsome Therapeutics, Inc. | $122.28 | 1 |
| ARGENX US, INC. | $55.50 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $21.49 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.46 | 1 |
| SK Life Science, Inc. | $16.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.60 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280410 | CMS |
| ABBVIE INC. | $9.45 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280412 | CMS |
| ABBVIE INC. | $8.43 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280414 | CMS |
| ABBVIE INC. | $4.77 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280416 | CMS |
| ABBVIE INC. | $2.93 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280418 | CMS |
| ABBVIE INC. | $6.94 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280420 | CMS |
| ABBVIE INC. | $12.02 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280422 | CMS |
| ABBVIE INC. | $3.87 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280424 | CMS |
| ABBVIE INC. | $9.34 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280426 | CMS |
| ABBVIE INC. | $8.53 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280428 | CMS |
| ABBVIE INC. | $3.68 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280430 | CMS |
| ABBVIE INC. | $16.88 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280432 | CMS |
| ABBVIE INC. | $5.58 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280434 | CMS |
| ABBVIE INC. | $10.52 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280436 | CMS |
| ABBVIE INC. | $11.77 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280438 | CMS |
| ABBVIE INC. | $6.00 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280440 | CMS |
| ABBVIE INC. | $12.77 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280442 | CMS |
| ABBVIE INC. | $7.96 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280444 | CMS |
| ABBVIE INC. | $15.33 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280446 | CMS |
| ABBVIE INC. | $4.17 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280448 | CMS |
| ABBVIE INC. | $6.83 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280450 | CMS |
| ABBVIE INC. | $1.63 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280452 | CMS |
| ABBVIE INC. | $3.47 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280454 | CMS |
| ABBVIE INC. | $13.76 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280456 | CMS |
| ABBVIE INC. | $14.24 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280458 | CMS |
| ABBVIE INC. | $9.74 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280460 | CMS |
| ABBVIE INC. | $13.61 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280462 | CMS |
| ABBVIE INC. | $10.21 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280464 | CMS |
| ABBVIE INC. | $5.85 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280466 | CMS |
| ABBVIE INC. | $8.36 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280468 | CMS |
| ABBVIE INC. | $5.81 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106280470 | CMS |
| Alexion Pharmaceuticals, Inc. | $20.46 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093946966 | CMS |
| ARGENX US, INC. | $55.50 | 09/26/2024 | Education | Undisputed | 01/23/2026 | 1142121922 | CMS |
| Axsome Therapeutics, Inc. | $122.28 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148300678 | CMS |
| Boston Scientific Corporation | $21.49 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092264068 | CMS |
| SK Life Science, Inc. | $16.49 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154142147 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.